P.A.C.C.S - Pharmacy & DME Providers Solutions

As we move through 2026, providers of Medical Immunizations and Durable Medical Equipment face a more rigorous regulatory landscape that prioritizes continuous oversight over static credentialing. The PECOS 2.0 Provider Data Management system now utilizes real-time monitoring for professional and state business licenses, meaning a single lapse in certification can trigger an automated deactivation warning through the Identity and Access system. Success in this environment requires a proactive approach to Medicare Part B enrollment to ensure that billing privileges remain uninterrupted. Furthermore, institutional providers and DMEPOS suppliers must account for the updated 2026 CMS enrollment application fee , which has been finalized at $750 for all initial enrollments and re-validations. The Shift to an Annual 12-Month DMEPOS Re-Accreditation Cycle Beginning January 1, 2026, the Centers for Medicare and Medicaid Services significantly reduced the survey and re-accreditation period f...

                      The Distinction Between Payer Directory Attestations and Medicare PDM In the current 2026 regulatory environment, providers must distinguish between two different types of data management. While the Medicare PECOS 2.0 Provider Data Management system governs your actual billing privileges and ownership records, the No Surprises Act mandates a separate 90-day attestation for private payer directories. For DMEPOS suppliers and pharmacies, missing a single 90-day cycle for these private plans does not just create a clerical error; it leads to the immediate removal of your facility from insurance directories. When a facility is removed from these directories, it appears as out-of-network to patients, leading to lost revenue and unnecessary claim delays even if your contract is technically still active. Mandatory 90-Day Verification Cycles for Private Insurance Networks The 90-day attestation requirement ...